Indoco And Aspen Agree On License Deal

Indian-based drugmaker Indoco has signed a licensing deal with South Africa's Aspen Pharmacare to allow the African firm to market a selection of ophthalmic products. Indoco will manufacture the medicines from US FDA-approved sites while Aspen will be responsible for obtaining regulatory approval in markets where it intends to sell the

To read the full article, please choose one of the following options: